- To review the currently available lipid-lowering therapies.
- To understand the Inclusion criteria, methods, and results of ORION 10 and 11 trials that investigated the use of Inclisiran as a lipid lowering therapy.
- To critically examine and Identify the strengths and limitation of the trial design for ORION 10 and 11.
07/29/2022 - 7:30am to 8:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Kifah Hussain, MD